Jonathan McNeill, President and COO: Crescent Biopharma CBIO Planned sale · Filed 09/17

Trade details

Type: Planned sale notice
Stock: Crescent Biopharma CBIO
Person: Jonathan McNeillPresident and COO
Planned sale date: 26/09/18
Filed: 26/09/17

More to sell after $382.9K in 3 months

Crescent Biopharma trades, last 26 weeks

What else happened in Crescent Biopharma around then

Filed or reported within 30 days of the trade day · 08/19~10/18

Jonathan McNeill's recent trades

Jonathan McNeillPresident and COO
Planned sale10b5-1 planCrescent Biopharma
Planned sale10b5-1 plan
Crescent Biopharma
CBIO
$15.1K
804 sh
$15.1K
Filed 09/16
Traded 09/16
Jonathan McNeillPresident and COO
Sell10b5-1 planCrescent Biopharma
Sell10b5-1 plan
Crescent Biopharma
CBIO
$369.7K
20,549 sh
$369.7K
Filed 06/23
Traded 06/22
Jonathan McNeillChief Business Officer
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 plan
Dyne Therapeutics
DYN
$108K
2,400 sh
$108K
Filed 24/08/20
Traded 24/08/19
Jonathan McNeillChief Business Officer
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 plan
Dyne Therapeutics
DYN
$14K
305 sh
$14K
Filed 24/08/20
Traded 24/08/19
Jonathan McNeillChief Business Officer
SellDyne Therapeutics
Sell
Dyne Therapeutics
DYN
$57.1K
1,823 sh
$57.1K
Filed 24/06/11
Traded 24/06/11

Jonathan McNeill, COO — plans to sell 4,415 sh of Crescent Biopharma CBIO · $75.8K · around 09/18 · 10b5-1 plan | Whalegun